Rationing of drugs for rare diseases

Pharmacoeconomics. 2006;24(4):315-6. doi: 10.2165/00019053-200624040-00001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis
  • Health Care Rationing*
  • Health Services Accessibility
  • Humans
  • Orphan Drug Production / economics*
  • Patient Rights
  • Rare Diseases / drug therapy
  • Rare Diseases / economics*
  • Risk Sharing, Financial